Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Clinical trial NCT00818649 · TERMINATED
Trial details
- NCT number
- NCT00818649
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2012-05-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.